Table 1.

Studies reporting chemotherapy efficacy in patients with BRCA1 or BRCA2 mutations

Abbreviations: AC, doxorubicin, cyclophosphamide; AT, doxorubicin, docetaxel; cCR, clinical complete response; CMF, cyclophosphamide methotrexate, 5-flourouracil; CMFP, cyclophosphamide methotrexate, 5-flourouracil, prednisone; CR, complete response; FAC, flourouracil, doxorubicin, cyclophosphamide; HR, hormone receptor; ORR, overall response rate; OS, overall survival; pCR, pathological complete response; PFS, progression-free survival; PR, partial response; TNBC, triple-negative breast cancer; TTP, time to progression.